(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -310.86%-1.67M | -155.73%-2.54M | -128.89%-1.17M | -69.82%-1.44M | 58.66%-733K | -74.78%792K | 133.42%4.57M | 355.24%4.04M | 80.11%-845K | 64.48%-1.77M |
Net income from continuing operations | -98.49%-5M | -33.66%-15.48M | -24.96%-6.14M | -56.82%-3.24M | -18.92%-3.58M | -58.35%-2.52M | 8.77%-11.58M | -17.65%-4.91M | 29.22%-2.07M | 18.55%-3.01M |
Operating gains losses | 444.88%438K | -198.94%-750K | -202.44%-587K | 193.42%213K | -277.86%-249K | -146.52%-127K | -58.76%758K | -72.87%573K | 63.69%-228K | 37.25%140K |
Depreciation and amortization | 2.19%1.12M | 22.40%4.33M | -1.66%1.01M | 48.84%1.09M | 41.91%1.13M | 11.93%1.1M | 82.17%3.54M | 86.36%1.03M | 39.35%733K | 78.70%797K |
Asset impairment expenditure | ---- | --4.69M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Remuneration paid in stock | 58.81%640K | -14.56%1.84M | -38.55%365K | 77.17%675K | -31.36%394K | -32.95%403K | 4.22%2.15M | 93.49%594K | -51.22%381K | -18.58%574K |
Deferred tax | 0.00%-125K | -1,144.44%-2.69M | -4,183.33%-2.31M | -127.27%-125K | -135.85%-125K | -131.48%-125K | -71.43%-216K | -370.00%-54K | 62.33%-55K | ---53K |
Other non cashItems | 30.34%2.29M | 37.92%7.63M | 5.21%1.96M | 52.15%2.12M | 37.84%1.8M | 80.21%1.76M | 23.91%5.54M | 18.21%1.86M | 45.21%1.39M | 45.26%1.3M |
Change In working capital | -47.39%969K | -48.78%4.48M | -76.36%1.53M | -489.16%-323K | 390.47%1.43M | -31.29%1.84M | 222.29%8.76M | 1,625.65%6.48M | 104.09%83K | 81.58%-493K |
-Change in receivables | 178.86%1.62M | -95.51%229K | -75.58%1.63M | -1.64%-2.17M | 412.14%2.83M | -51,550.00%-2.06M | 254.42%5.1M | 277.60%6.68M | -239.67%-2.14M | 152.52%552K |
-Change in inventory | -128.27%-214K | -68.35%1.32M | -88.87%512K | -8.23%-999K | -59.05%1.05M | 136.55%757K | 157.11%4.17M | 396.22%4.6M | 74.45%-923K | 221.75%2.56M |
-Change in prepaid assets | -36.22%118K | -50.00%22K | -117.15%-59K | 2,477.78%214K | -20.00%-318K | 811.54%185K | 119.05%44K | 142.52%344K | -101.95%-9K | -165.43%-265K |
-Change in payables and accrued expense | -118.86%-558K | 619.25%2.91M | 89.27%-552K | -16.43%2.63M | 36.39%-2.13M | -38.04%2.96M | -115.25%-561K | -259.72%-5.14M | 868.78%3.15M | -4,558.67%-3.34M |
Interest paid (cash flow from operating activities) | -30.29%-2M | -50.90%-6.6M | -10.07%-1.68M | -69.92%-1.85M | -48.69%-1.53M | -111.72%-1.54M | -9.55%-4.37M | 1.23%-1.53M | -37.42%-1.09M | -34.16%-1.03M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -310.86%-1.67M | -155.73%-2.54M | -128.89%-1.17M | -69.82%-1.44M | 58.66%-733K | -74.78%792K | 133.42%4.57M | 355.24%4.04M | 80.11%-845K | 64.48%-1.77M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 31.07%-528K | 86.82%-2.71M | 96.34%-361K | 87.64%-907K | 58.63%-671K | 54.75%-766K | -1.34%-20.52M | -370.35%-9.87M | -664.48%-7.34M | 89.82%-1.62M |
Net PPE purchase and sale | 24.25%-528K | 82.40%-2.63M | 94.95%-501K | 51.19%-864K | 68.14%-570K | 52.46%-697K | -250.70%-14.95M | -470.30%-9.93M | -108.24%-1.77M | -225.27%-1.79M |
Net business purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | 65.71%-5.3M | 206.25%34K | ---- | ---- |
Net other investing changes | ---- | 72.35%-73K | 418.52%140K | 81.39%-43K | -160.48%-101K | 69.60%-69K | 48.94%-264K | 108.31%27K | -2,466.67%-231K | 415.09%167K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 31.07%-528K | 86.82%-2.71M | 96.34%-361K | 87.64%-907K | 58.63%-671K | 54.75%-766K | -1.34%-20.52M | -370.35%-9.87M | -664.48%-7.34M | 89.82%-1.62M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -235.38%-929K | -94.94%833K | -133.57%-2.17M | -96.55%77K | -56.56%3.2M | -166.91%-277K | -54.76%16.46M | 15.19%6.45M | 29.45%2.23M | -6.94%7.36M |
Net issuance payments of debt | -556.32%-1.82M | -133.49%-3.56M | -130.71%-2.1M | -96.78%77K | -199.37%-1.26M | -309.85%-277K | -18.33%10.63M | 25.49%6.84M | 50.16%2.39M | -84.09%1.27M |
Net common stock issuance | --889K | -19.78%4.44M | --0 | --0 | --4.44M | --0 | -73.32%5.54M | -51.74%-393K | -515.38%-160K | ---- |
Proceeds from stock option exercised by employees | ---- | -117.47%-51K | -1,200.00%-66K | --0 | ---- | ---- | -88.78%292K | -98.54%6K | -99.37%1K | -95.89%3K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -235.38%-929K | -94.94%833K | -133.57%-2.17M | -96.55%77K | -56.56%3.2M | -166.91%-277K | -54.76%16.46M | 15.19%6.45M | 29.45%2.23M | -7.15%7.36M |
Net cash flow | ||||||||||
Beginning cash position | -38.45%7.3M | 11.31%11.86M | -1.96%11.12M | -20.93%13.21M | -6.17%11.61M | 11.31%11.86M | 31.32%10.66M | 30.07%11.34M | 38.22%16.7M | -50.73%12.37M |
Current changes in cash | -1,145.82%-3.13M | -972.73%-4.42M | -689.31%-3.7M | 61.94%-2.27M | -54.77%1.8M | -113.49%-251K | -79.56%506K | -67.33%627K | -70.86%-5.95M | 130.53%3.97M |
Effect of exchange rate changes | 14,200.00%143K | -120.60%-144K | -14.68%-125K | -69.65%180K | -156.02%-200K | 100.70%1K | 959.09%699K | -781.25%-109K | 390.08%593K | 1,290.00%357K |
End cash Position | -62.83%4.32M | -38.45%7.3M | -38.45%7.3M | -1.96%11.12M | -20.93%13.21M | -6.17%11.61M | 11.31%11.86M | 11.31%11.86M | 30.07%11.34M | 38.22%16.7M |
Free cash from | -2,413.68%-2.2M | 50.70%-5.18M | 71.64%-1.67M | 12.08%-2.3M | 64.51%-1.3M | -94.32%95K | 41.43%-10.5M | -77.02%-5.89M | 48.71%-2.62M | 33.76%-3.67M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data